Takeda Opens German Plant for Dengue Vaccine Production
Takeda Opens German Plant for Dengue Vaccine Production
GALWAY, IRELAND--November 18, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Takeda Pharmaceutical (Osaka, Japan) has officially opened its new manufacturing plant in Singen, Germany, for its planned dengue vaccine, TAK-003, which is still in Phase 3 trials.
Within this article: Details opening of new plant, planned dengue vaccine, investment, schedule, related Takeda business and assets sales
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- Suffolk Construction Has Hand in $1.8 Billion Worth of U.S. Projects, Mostl...
- New England Sees $23.3 Billion in Projects Under Construction
- Takeda Completes $62 Billion Shire Acquisition, an Industrial Info Market B...
- ISPE Names the 2018 Pharmaceutical Facility of the Year Category Awards